All In Biotech

Drug Trial Radar · NCT07114874

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

A Global, Phase 3, Multicenter, Open-Label Study to Assess the Long-Term Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia

Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Jul 11, 2025

Primary completion

Dec 2031

Study completion Dec 2031

Sponsor

Lead sponsor
Neurocrine BiosciencesNeurocrine Biosciences (NBIX)
Sponsor type
Industry
First posted
Aug 11, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.

Conditions

  • Schizophrenia

Interventions

  • NBI-1117568Drug

    NBI-1117568 will be administered per schedule specified in the arm description.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Treatment-emergent Adverse EventsTime frame: Up to 36 months

Locations

61 sites in 5 countries. Site status is shown where the registry gives one.

  • Neurocrine Clinical Site

    Bryant, Arkansas · Recruiting

  • Neurocrine Clinical Site

    Little Rock, Arkansas · Recruiting

  • Neurocrine Clinical Site

    Cerritos, California · Recruiting

  • Neurocrine Clinical Site

    Chino, California · Recruiting

  • Neurocrine Clinical Site

    Culver City, California · Recruiting

  • Neurocrine Clinical Site

    Garden Grove, California · Recruiting

  • Neurocrine Clinical Site

    La Habra, California · Recruiting

  • Neurocrine Clinical Site

    Lemon Grove, California · Recruiting

  • Neurocrine Clinical Site

    Oceanside, California · Recruiting

  • Neurocrine Clinical Site

    Pico Rivera, California · Recruiting

  • Neurocrine Clinical Site

    Riverside, California · Recruiting

  • Neurocrine Clinical Site

    San Diego, California · Recruiting

  • Neurocrine Clinical Site

    Sherman, California · Recruiting

  • Neurocrine Clinical Site

    Torrance, California · Recruiting

  • Neurocrine Clinical Site

    West Hills, California · Completed

  • Neurocrine Clinical Site

    Atlantis, Florida · Recruiting

  • Neurocrine Clinical Site

    Aventura, Florida · Recruiting

  • Neurocrine Clinical Site

    Doral, Florida · Withdrawn

  • Neurocrine Clinical Site

    Hollywood, Florida · Recruiting

  • Neurocrine Clinical Site

    Maitland, Florida · Recruiting

  • Neurocrine Clinical Site

    Miami, Florida · Recruiting

  • Neurocrine Clinical Site

    Miami, Florida · Withdrawn

  • Neurocrine Clinical Site

    Miami Lakes, Florida · Recruiting

  • Neurocrine Clinical Site

    Tampa, Florida · Recruiting

  • Neurocrine Clinical Site

    West Palm Beach, Florida · Recruiting

  • Neurocrine Clinical Site

    Atlanta, Georgia · Recruiting

  • Neurocrine Clinical Site

    Atlanta, Georgia · Recruiting

  • Neurocrine Clinical Site

    Decatur, Georgia · Recruiting

  • Neurocrine Clinical Sites

    Peachtree Corners, Georgia · Recruiting

  • Neurocrine Clinical Site

    Chicago, Illinois · Recruiting

  • Neurocrine Clinical Site

    Oak Brook, Illinois · Recruiting

  • Neurocrine Clinical Site

    Gaithersburg, Maryland · Recruiting

  • Neurocrine Clinical Site

    Boston, Massachusetts · Recruiting

  • Neurocrine Clinical Site

    Watertown, Massachusetts · Recruiting

  • Neurocrine Clinical Site

    Flowood, Mississippi · Recruiting

  • Neurocrine Clinical Site

    St Louis, Missouri · Recruiting

  • Neurocrine Clinical Site

    Marlton, New Jersey · Recruiting

  • Neurocrine Clinical Site

    Cedarhurst, New York · Recruiting

  • Neurocrine Clinical Site

    New York, New York · Recruiting

  • Neurocrine Clinical Site

    New York, New York · Recruiting

Showing 40 of 61 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.